In support of this speculation, SCs were treated with cisplatin plus 5AZA (a well-known demethylating agent used in different chemotherapy treatments of tumor pathologies) obtaining an up-regulation of GDNF expression comparable to that induced by EPA treatment, even though the treatment with fatty acid showed a greater efficacy. The gene discussed is GDNF; the disease is neoplasm.